Calculus Capital invests £3m in developer of cutting-edge diagnostic technologies Private equity specialist Calculus Capital has made a multi-million-pound investment in Bedford-based Mologic, a developer of cutting-edge point-of-care diagnostic devices that help patients manage their own conditions. The £3m investment aims to enable Mologic to commercialise innovative medical diagnostic technology, carry out clinical trials and … Continued
Calculus Capital has been named runner up for ‘Best EIS Investment Manager’ and ‘Growth Investor of the Year’ at the inaugural Growth Investor Awards, which recognises impact beyond investment in the UK SME finance industry. The Best EIS Investment Manager award, recognises a top performing fund manager specialising in Enterprise Investment Schemes. This award is judged … Continued
Benito’s Hat was mentioned in CITY AM’s article on the rise of Mexican food outlets in London. The article compares the different Mexican food chains available. For the full article please click here.Fast food has become fashionable in London and the burrito has become one of the trendiest meals in town. Benito’s Hat founder Ben Fordham … Continued
Madeleine Ingram, Calculus Capital, London, 25 August 2015. WealthBriefing.com Calculus Capital is the focus of this wealthbriefing.com article on how the UK’s Enterprise Investment Scheme landscape is shifting and where Calculus Capital sits in the new EIS market. By Tom Burroughes. In the first part of a feature examining the views of practitioners within the … Continued
Calculus Capital’s investment in Synpromics was featured in The Scotsman: An Edinburgh based biotech firm that is helping to find cures for haemophilia and hereditary blindness has secured a £2.1 million investment to develop its gene therapies. Synpromics, based at the city’s BioQuarter life sciences incubator, received the cash injection from private equity firm Calculus Capital, which … Continued
Private equity fund manager Calculus Capital has invested £2.1m in Synpromics, a Scottish-based synthetic biology company. The funds will be used for business expansion and further development of Synpromics’ proprietary synthetic promoter technology. Synpromics is a privately backed synthetic biology business with unique IP and know-how in the development and application of synthetic promoters. Synthetic promoters … Continued
We’re delighted to share that Calculus Capital has been short-listed for the ‘Best EIS Investment Manager’ and ‘Best Growth Investor’ for the 2015 Growth Investor Awards, which recognises impact beyond investment in the UK SME fund management industry. The winners will be revealed at the Growth Investor Awards black tie dinner held on 22 October at the … Continued
We’re delighted to share news from one of our portfolio companies, Chop’d, a leading salad bar chain dedicated to using only the best, locally sourced ingredients. See below press release on their new partnership with Costa Coffee. The nation’s favourite coffee shop brand Costa has launched a trial partnership with London salad brand Chop’d to offer fresh salads … Continued
Latest news from our portfolio company inspiresport, who have expanded their offering and have recently signed a deal with China Britain Travel Group to bring young players from China to the UK. See the press release below: The UKs number one youth sports development tour company inspiresport is further expanding its’ international reach, thanks to … Continued
Private Equity wire announces Calculus Capital’s latest hire, Alexander Crawford, Investment Director.Private equity firm Calculus Capital, a specialist in Enterprise Investment Scheme (EIS) funds, has appointed Alexander Crawford as Investment Director. Alexander has over 20 years’ corporate finance experience, including ten years with Robert Fleming & Co, Evercore Partners and JP Morgan in London, New … Continued